Zdrowie i gospodarka · 11/07/2018

FDA Requests Public Comment on Proposed Collection of Postmarketing Adverse Drug Experience Reporting and Recordkeeping Information

The Food and Drug Administration (FDA) is seeking public input on its proposed collection of information related to postmarketing adverse drug experience reporting and recordkeeping, as required by the Paperwork Reduction Act of 1995